Organisation paid for research Program year 2025 Source: CMS Open Payments

Remington-Davis Inc

Neither a doctor nor a teaching hospital

Research payments

$850,148

179 payments

Through program year 2025, Remington-Davis Inc is reported as receiving $850,148 in research payments, across 179 payments.

By program year

6 rows
Year Kind Amount Payments
2025 Research $118,754 35
2024 Research $373,422 76
2023 Research $91,680 25
2022 Research $97,823 12
2021 Research $134,960 16
2020 Research $33,507 15

Breakdown

Who paid Research payments · program years 2020–2025
  1. GlaxoSmithKline, LLC. $285,182 45 payments
  2. Abbott Laboratories $233,677 50 payments
  3. AbbVie, Inc. $162,246 54 payments
  4. Acrotech Biopharma LLC $84,108 15 payments
  5. Verona Pharma, Inc. $46,001 7 payments
  6. Braintree Laboratories, Inc. $24,934 7 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $14,000 1 payment
Studies the money was for Research payments · program years 2020–2025
  1. A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel-Arm $189,013 13 payments
  2. Abbott Sensor Based Monitoring System Multiple Analyte Characterization Study Using Venous and/or Ca $144,798 5 payments
  3. A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA) $142,618 45 payments
  4. A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Cont $96,169 32 payments
  5. 246-13651-302 $64,016 6 payments
  6. A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD $46,001 7 payments
  7. Abbott Sensor Based Monitoring System Multiple Analyte Characterization Study Using Venous and/or Capillary Reference $36,242 22 payments
  8. Frequency of Ketosis in People Living with Diabetes or Other Medical Conditions $31,970 10 payments
  9. Multi-Analyte Studies $19,610 10 payments
  10. 246-13651-301 $15,333 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record